DOI: https://doi.org/10.22141/2224-0713.6.100.2018.146453

Pathogenesis and the modern comprehensive approach to the treatment of pain syndromes in neurology

T.M. Slobodin, I.H. Maslova

Abstract


The article deals with the problem of pain syndrome in neurology. The pathogenesis of its development is considered, as well as some aspects of treatment.

Keywords


pain syndrome; neuropathic pain; diabetic polyneuropathy; fibromyalgia; pregabalin; memantine

References


Baron R. Neuropathic pain: diagnosis, pathophysiological mechanisms and treatment // The Lancet. — 2010. — Vol. 9. — P. 807-819.

Baron R. Mechanisms of disease: neuropathic pain — a clinical perspective // Nat. Clin. Pract. Neurol. — 2006. — Vol. 2. — P. 95-106.

Amir R., Kocsis J.D., Devor M. Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons // J. Neurosci. — 2005. — Vol. 25. — P. 2576-2585.

Wu G., Ringkamp M., Murinson B.B. et al. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents // J. Neurosci. — 2002. — Vol. 22. — P. 7746-7753.

Bostock H., Campero M., Serra J., Ochoa J.L. Temperature-dependent double spikes in C-nociceptors of neuropatic pain patients // Brain. — 2005. — Vol. 128. — P. 2154-2163.

Hains B.C., Waxman S.C. Sodium channel expression and the molecular pathophysiology of pain after SCI // Prog. Brain Res. — 2007. — Vol. 161. — P. 195-203.

Dib-Hajj S.D., Black J.A., Waxman S.C. Voltage-gated sodium cannels: therapeutic targets for pain // Pain Med. — 2009. — Vol. 10. — P. 1260-1269.

Orstavik K., Jorum E. Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy // Neurosci Lett. — 2010. — Vol. 470. — P. 108-114.

Orstavik K., Weidner C., Schmidt R. et al. Pathological C-fibres in patients with a chronic painful condition // Brain. — 2003. — Vol. 126. — P. 567-578.

Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia // Nat. Neurosci. — 2007. — Vol. 10. — P. 1361-1368.

Saab C.Y., Waxman S.C., Hauns B.C. Alarm or curse? The pain of neuroinflammation // Brain Res Rev. — 2008. — Vol. 58. — P. 226-235.

Milligan E.D., Watkins I.R. Pathological and protective roles of glia in chronic pain // Nat. Rev. Neurosci. — 2009. — Vol. 10. — P. 23-36.

Moore K.A., Kohno T., Karchewski I.A. et al. Partial periphe-ral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord // J. Neurosci. — 2002. — Vol. 22. — P. 6724-6731.

Scholz J., Broom D.C., Youn D.N. et al. Blocking caspase activity prevents transsinaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury //

J. Neurosci. — 2005. — Vol. 25. — P. 7317-7323.

Hains B.C., Saab C.Y., Klein J.P., Craner M.J., Waxman S.C. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury // J. Neurosci. — 2004. — Vol. 24. — P. 4832-4839.

Finnerup N.B., Jensen T.S. Spinal cord injury pain-mechanisms and treatment // Eur. J. Neurol. — 2004. — Vol. 11. — P. 73-82.

Ducreux D., Attal N., Parker F., Bouhasstra D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia // Brain. — 2006. — Vol. 128. — P. 963-976.

Wasner G., Lee B.B., Engel S., McLachlan E. Residual spinothalamic tract pathways predict development of central pain after apinal cord injury // Brain. — 2008. — Vol. 131. — P. 2387-2400.

Benedetti F. Loss of expectated-related mechanism in Alzheimer’s disease makes analgetic therapies less effective // Pain. — 2006. — Vol. 121. — P. 133-144.

Apkarian A.V., Sosa Y., Sonty S. et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density // J. Neurisci. — 2004. — Vol. 24(46). — P. 10410-10415.

Wiech, K., Ploner, M. & Tracey, I. Neurocognitive aspects of pain perception // Trends Cogn. Sci. — 2008. — Vol. 12. — P. 306-31.

Tracey, I. et al. Imaging attentional modulation of pain in the periaqueductal gray in humans // J. Neurosci. — 2002. — Vol. 22. — P. 2748-2752.

Valet, M. et al. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain — an fMRI analysis // Pain. — 2004. — Vol. 109. — P. 399-408.

Wiech K. & Tracey I. The influence of negative emotions on pain: behavioral effects and neural mechanisms // Neuroimage. — 2009. — Vol. 47. — P. 987-994.

Wiech K. et al. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain // J. Neurosci. — 2006. — Vol. 26. — P. 11501-11509.

Wager T.D., Davidson M.L., Hughes B.L., Lindquist M.A. & Ochsner K.N. Prefrontal-subcortical pathways mediating successful emotion regulation // Neuron. — 2008. — Vol. 59. — P. 1037-

Ochsner K.N. et al. Your pain or mine? Common and distinct neural systems supporting the perception of pain in self and other // Soc. Cogn. Affect. Neurosci. — 2008. — Vol. 3. — P. 144-160.

Phelps E.A., Delgado M.R., Nearing K.I. & LeDoux J.E. Extinction learning in humans: role of the amygdala and vmPFC // Neuron. — 2004. — Vol. 43. — P. 897-9.

Ploghaus A. et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network // J. Neurosci. — 2001. — Vol. 21. — P. 9896-9903.

Tracey I. getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans // Nature Medicine. — 2010. — Vol. 16 (11). — P. 1277-1283.

Koyama T., McHaffie J.G., Laurienti P.J. & Coghill R.C. The subjective experience of pain: where expectations become reality // Proc. Natl. Acad. Sci. USA. — 2005. — Vol. 102. — P. 12950-12955.

Zubieta J.K. et al. Placebo effects mediated by endogenous opioid activity on μ-opioid receptors // J. Neurosci. — 2005. — Vol. 25. — P. 7754-7762.

Wager T.D., Scott D.J. & Zubieta J.K. Placebo effects on human μ-opioid activity during pain // Proc. Natl. Acad. Sci. USA. — 2007. — Vol. 104. — P. 11056-1106.

Wasan A.D., Kaptchuk T.J., Davar G., Jamison R.N. The association between psychopathology and placebo analgesia in patients with discogenic low back pain // Pain Med. — 2006. — Vol. 7. — P. 217-228.

Geers A.L., Helfer S.G., Kosbab K., Weiland P.E. & Land-ry S.J. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations,and the placebo response // J. Psychosom. Res. — 2005. — Vol. 58. — P. 121-127.

Gelfland D.M., Gelfland S., Radin M. Some personality factors associated with placebo responsivity // Psychol. Rep. — 1965. — Vol. 17. — P. 555-562.

Bhandary A.K., Chimes G.P., Malanga G.A. Investigation pharmacology for low back pain // J. Pain Res. — 2010. — Vol. 3. — P. 169-181.

Freynhagen R., Baron R. Thee valuation of neuropatic components in low back pain // Curr. Pain Headache Rep. — 2009. — Vol. 13 (3). — P. 185-190.

Cruccu G., Sommer C., Anand P. et al. EFNS guidelines on neuropathic pain assessment: revised 2009 // Eur. J. Neurol. —

Finnerup N.B., Sindrup H.S., Jensen T.S. The evidence for pharmacological treatment of neuropathic pain // Pain. — 2010. — Vol. 150. — P. 573-581.

O’Connor A.B., Dworkin R.H. Treatment of neuropathic pain: an overview of recent guidelines // Am. J. Med. — 2009. — Vol. 122. — P. S22-32.

Dworkin R.H., O’Connor A.B., Audette J. et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update // Mayo Clin. Proc. — 2010. — Vol. 85. — P. S3-14.

Attal N., Cruccu G., Baron R. et al. EFNS guidelines on the pharmacological treatment on neuropathic pain: 2009 revision // Eur. J. Neurol. — 2010; published online April 9.

Martinez J.A., Kasamatsu M., Rosales-Hernandes A., Hanson L.R. Comparison of central versus peripheral delivery of pregabaline // Mol. Pain. — 2012. — Vol. 8 (Published online 2012 January 11. doi: 10.1186/1744-8069-8-3).

Baron R., Mayoral V., Leijon G., Binder A., Steigerwald I., Serpell M. Efficacy and safety of combination therapy with 5 % lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy // Curr. Med. Res. Opin. — 2009. — Vol. 25. — P. 1677-1687.

Gilron I., Bailey J.M., Tu D., Holden R.R. et al. Morphine, gabapentin, or their combination for neuropathic pain // N. Engl. J. Med. — 2005. — Vol. 352. — P. 1324-1334.

Hanna M., O’Brien C., Wilson M.C. Prolonged-release oxycodone enhances the eff ects of existing gabapentin therapy in painful diabetic neuropathy patients // Eur. J. Pain. — 2008. — Vol. 12. — P. 804-813.

Сергеев А.В., Табеева Г.Р., Азимова Ю.Э. Центральная нейрональная гипервозбудимость — предиспозиция к мигрени // Российский журнал боли. — 2010. — № 2. — С. 3-9.

Schwedt J., Dodick D.W. Advanced neuroimaging of migraine // Lancet. — 2009. — Vol. 8. — P. 560-568.

Pizzolato R., Villani V., Prosperini L. Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study // J. Headache Pain. — 2011. — Vol. 12(5). —

P. 521-525.

Calandre E.P., Garcia-Leiva J.M., Rico-Villademoros F., Vilchez J.S., Rodriguez-Lopez C.M. Pregabalin in the treatment of chronic migraine: an open-label study // Clin. Neuropharmacol. — 2010. — Vol. 33(1). — P. 35-39.




Copyright (c) 2018 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта